93
Participants
Start Date
February 28, 2006
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
melphalan
Given throug isolated hepatic artery infusion
regional chemotherapy
Patients receive the best alternative therapy
systemic chemotherapy
Patients receive the best alternative therapy
hepatic artery embolization
Patients receive the best alternative therapy
Cancer Center of Albany Medical Center, Albany
UPMC Cancer Centers, Pittsburgh
St. Luke's Cancer Network at St. Luke's Hospital, Bethlehem
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore
Swedish Medical Center, Englewood
John Wayne Cancer Institute at Saint John's Health Center, Santa Monica
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda
Carol G. Simon Cancer Center at Morristown Memorial Hospital, Morristown
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus
Providence Cancer Center at Providence Portland Medical Center, Portland
University of Texas Medical Branch, Galveston
National Cancer Institute (NCI)
NIH
Delcath Systems Inc.
INDUSTRY